[Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
作者信息
Aleksandrowicz J, Blicharski J, Skotnicki A, Retinger M, Zduńczyk A
出版信息
Pol Tyg Lek. 1981 Aug 31;36(35):1363-5.
PMID:7036112
Abstract
摘要
相似文献
1
[Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].[多发性硬化症免疫发病机制的各个方面及治疗可能性]
Pol Tyg Lek. 1981 Aug 31;36(35):1363-5.
2
[Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].[多发性硬化症期间中枢神经系统局部免疫与全身免疫的相互作用]
Rev Neurol (Paris). 1972 Nov;127(5):497-504.
3
[Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. I].多发性硬化症的临床、自身免疫及神经病理学方面。I
Proc K Ned Akad Wet C. 1972;75(4):257-75.
4
[Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. II].[多发性硬化症的临床、自身免疫和神经病理学方面。II]
Proc K Ned Akad Wet C. 1972;75(4):276-86.
5
[Multiple sclerosis: new pathogenetic and diagnostic data].[多发性硬化症：新的发病机制和诊断数据]
Neurol Neurochir Pol. 1987 Jan-Feb;21(1):66-70.
6
[Experiences with immunosuppressive treatment of multiple sclerosis].[多发性硬化症免疫抑制治疗的经验]
Dtsch Gesundheitsw. 1971 Sep 16;26(38):1791-4.
7
Immunopathogenesis of multiple sclerosis: implications for treatment.
Ir Med J. 2004 Jan;97(1):5-6.
8
[Multiple sclerosis: from immunopathogenesis to disease management].
Nervenarzt. 1996 Dec;67(12 Suppl Von Der Im):1-8.
9
[Immunosuppressive treatment of multiple sclerosis (review of the literature].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(2):119-26.
10
[Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
MMW Fortschr Med. 2008 Apr 10;150(15):17.
引用本文的文献
1
Therapeutic application of calf thymus extract (TFX).小牛胸腺提取物（TFX）的治疗应用。
Med Oncol Tumor Pharmacother. 1989;6(1):31-43. doi: 10.1007/BF02985221.
Zotero 插件